ShanX Medtech receives the MIT feasibility study 2022

ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy.

This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally mapping out the opportunities of this project. With this project we will gain a deeper understanding of the necessary resources to implement said project.

Share this post